178 related articles for article (PubMed ID: 9820002)
1. [Activated protein C resistance--a recently discovered hereditary thrombophilia].
Moland L; Sandset PM
Tidsskr Nor Laegeforen; 1998 Sep; 118(23):3590-5. PubMed ID: 9820002
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of three reactants for the detection of activated protein C resistance due to mutation of factor V Leiden during pregnancy].
Magdelaine A; Soubrier F; Berkane N; Uzan S; Verdy E
Ann Biol Clin (Paris); 1998; 56(4):445-50. PubMed ID: 9754280
[TBL] [Abstract][Full Text] [Related]
3. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
[TBL] [Abstract][Full Text] [Related]
4. Activated protein C resistance--a major risk factor for thrombosis.
Rosén SB; Sturk A
Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
[TBL] [Abstract][Full Text] [Related]
5. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis of thrombophilia based on coagulation and genetic studies].
Bałszan-Kowalska I
Ann Acad Med Stetin; 2002; 48():179-93. PubMed ID: 14601477
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of a new functional test for detection of activated protein C resistance (Pefakit APC-R Factor V Leiden) at two centers in Europe and the USA.
Schöni R; Quehenberger P; Wu JR; Wilmer M
Thromb Res; 2007; 119(1):17-26. PubMed ID: 16934314
[TBL] [Abstract][Full Text] [Related]
8. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
Dahlbck B
J Intern Med Suppl; 1997; 740():1-8. PubMed ID: 9350175
[TBL] [Abstract][Full Text] [Related]
9. Resistance to activated protein C: a major cause of inherited thrombophilia.
Jensen R; Ens GE
Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621
[TBL] [Abstract][Full Text] [Related]
10. [National evaluation of the diagnosis of activated protein C resistance].
Montiel-Manzano G; de la Peña-Díaz A; Majluf-Cruz A; Cesarman-Maus G; Corona-de la Peña N; Cruz-Cruz D; Gaminio E; Martínez-Murillo C; Mayagoitia T; Miranda-Peralta E; Poblete T; Quintana-Martínez S; Ramírez R; Razo D; Ruiz de Chávez-Ochoa A; Reyes-Núñez VA; Salazar R; Vicencio-Santiago GV; Villa R
Rev Invest Clin; 2003; 55(3):358-69. PubMed ID: 14515684
[TBL] [Abstract][Full Text] [Related]
11. Factor V:Q506 mutation-resistance to activated protein C (APC): clinical implications with respect to family screening.
Middeldorp S; van der Meer J
Semin Thromb Hemost; 1998; 24(4):363-6. PubMed ID: 9763353
[TBL] [Abstract][Full Text] [Related]
12. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
[TBL] [Abstract][Full Text] [Related]
13. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis.
Dahlbäck B
Thromb Haemost; 1997 Jul; 78(1):483-8. PubMed ID: 9198201
[TBL] [Abstract][Full Text] [Related]
14. Screening for inherited thrombophilia: indications and therapeutic implications.
De Stefano V; Rossi E; Paciaroni K; Leone G
Haematologica; 2002 Oct; 87(10):1095-108. PubMed ID: 12368166
[TBL] [Abstract][Full Text] [Related]
15. Inherited thrombophilic states.
Rao AK; Kaplan R; Sheth S
Semin Thromb Hemost; 1998; 24 Suppl 1():3-12. PubMed ID: 9840687
[TBL] [Abstract][Full Text] [Related]
16. The VITA Project: heritability of resistance to activated protein C. Vincenza Thrombophilia and Arteriosclerosis.
Tosetto A; Castaman G; Cappellari A; Rodeghiero F
Thromb Haemost; 2000 Nov; 84(5):811-4. PubMed ID: 11127861
[TBL] [Abstract][Full Text] [Related]
17. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM
Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
[TBL] [Abstract][Full Text] [Related]
19. [Pregnancy outcomes in a patient-heterozygous carrier of R506Q mutation of factor V (Leiden)].
Herman M; Djelmis J; Troselj Z; Ivanisević M
Acta Med Croatica; 2006 Jun; 60(3):277-80. PubMed ID: 16933843
[TBL] [Abstract][Full Text] [Related]
20. Incidence of venous thromboembolism in families with inherited thrombophilia.
Simioni P; Sanson BJ; Prandoni P; Tormene D; Friederich PW; Girolami B; Gavasso S; Huisman MV; Büller HR; Wouter ten Cate J; Girolami A; Prins MH
Thromb Haemost; 1999 Feb; 81(2):198-202. PubMed ID: 10063991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
